In this report, the study analysis was given on a worldwide scale, for instance, present and traditional Drug-Coated Balloonsgrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.
According to XYZResearch, the global Drug-Coated Balloons market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of Drug-Coated Balloons industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.
At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Drug-Coated Balloons in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Drug-Coated Balloons market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Natec Medical
Cook Medical
Medtronic
C.R. Bard
Boston Scientific
Spectranetics Corporation
Endocor GmbH
Biotronik
Cordis Corporation
Abbott Laboratories
Smiths Medical
Opto Circuits
Asahi Intecc
Angioslide
Tokai Medical
Atrium Medical
Lepu Medical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Material
Semi-Compliant Balloons
Non-Compliant Balloons
Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Drug-Coated Balloons for each application, including
Hospitals
Clinics
Ambulatory Surgical Centers
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Drug-Coated Balloons Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Drug-Coated Balloons Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 By Material Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Semi-Compliant Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Non-Compliant Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Drug-Coated Balloons Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Drug-Coated Balloons Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Drug-Coated Balloons Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Drug-Coated Balloons Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Drug-Coated Balloons Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Drug-Coated Balloons Market Assessment by Type
8.1 Asia Pacific Drug-Coated Balloons Market Assessment by Application (Consumption and Market Share)
8.2 North America Drug-Coated Balloons Market Assessment by Application (Consumption and Market Share)
8.3 Europe Drug-Coated Balloons Market Assessment by Application (Consumption and Market Share)
8.4 South America Drug-Coated Balloons Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Drug-Coated Balloons Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Natec Medical
9.1.1 Natec Medical Profiles
9.1.2 Natec Medical Product Portfolio
9.1.3 Natec Medical Drug-Coated Balloons Business Performance
9.1.4 Natec Medical Drug-Coated Balloons Business Development and Market Status
9.2 Cook Medical
9.2.1 Cook Medical Profiles
9.2.2 Cook Medical Product Portfolio
9.2.3 Cook Medical Drug-Coated Balloons Business Performance
9.2.4 Cook Medical Drug-Coated Balloons Business Development and Market Status
9.3 Medtronic
9.3.1 Medtronic Profiles
9.3.2 Medtronic Product Portfolio
9.3.3 Medtronic Drug-Coated Balloons Business Performance
9.3.4 Medtronic Drug-Coated Balloons Business Development and Market Status
9.4 C.R. Bard
9.4.1 C.R. Bard Profiles
9.4.2 C.R. Bard Product Portfolio
9.4.3 C.R. Bard Drug-Coated Balloons Business Performance
9.4.4 C.R. Bard Drug-Coated Balloons Business Development and Market Status
9.5 Boston Scientific
9.5.1 Boston Scientific Profiles
9.5.2 Boston Scientific Product Portfolio
9.5.3 Boston Scientific Drug-Coated Balloons Business Performance
9.5.4 Boston Scientific Drug-Coated Balloons Business Development and Market Status
9.6 Spectranetics Corporation
9.6.1 Spectranetics Corporation Profiles
9.6.2 Spectranetics Corporation Product Portfolio
9.6.3 Spectranetics Corporation Drug-Coated Balloons Business Performance
9.6.4 Spectranetics Corporation Drug-Coated Balloons Business Development and Market Status
9.7 Endocor GmbH
9.7.1 Endocor GmbH Profiles
9.7.2 Endocor GmbH Product Portfolio
9.7.3 Endocor GmbH Drug-Coated Balloons Business Performance
9.7.4 Endocor GmbH Drug-Coated Balloons Business Development and Market Status
9.8 Biotronik
9.8.1 Biotronik Profiles
9.8.2 Biotronik Product Portfolio
9.8.3 Biotronik Drug-Coated Balloons Business Performance
9.8.4 Biotronik Drug-Coated Balloons Business Development and Market Status
9.9 Cordis Corporation
9.9.1 Cordis Corporation Profiles
9.9.2 Cordis Corporation Product Portfolio
9.9.3 Cordis Corporation Drug-Coated Balloons Business Performance
9.9.4 Cordis Corporation Drug-Coated Balloons Business Development and Market Status
9.10 Abbott Laboratories
9.10.1 Abbott Laboratories Profiles
9.10.2 Abbott Laboratories Product Portfolio
9.10.3 Abbott Laboratories Drug-Coated Balloons Business Performance
9.10.4 Abbott Laboratories Drug-Coated Balloons Business Development and Market Status
9.11 Smiths Medical
9.12 Opto Circuits
9.13 Asahi Intecc
9.14 Angioslide
9.15 Tokai Medical
9.16 Atrium Medical
9.17 Lepu Medical
10 World Drug-Coated Balloons Market Assessment by Players
10.1 Global Drug-Coated Balloons Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Drug-Coated Balloons Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Drug-Coated Balloons Price (USD/Unit) of Players 2014-2020
10.4 Global Drug-Coated Balloons Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Drug-Coated Balloons Sales Assessment of Players 2014-2020
11.1.2 North America Drug-Coated Balloons Revenue Assessment of Players 2014-2020
11.1.3 North America Drug-Coated Balloons Price Assessment of Players 2014-2020
11.1.4 North America Drug-Coated Balloons Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Drug-Coated Balloons Sales Assessment of Players 2014-2020
11.2.2 Europe Drug-Coated Balloons Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Drug-Coated Balloons Price Assessment of Players 2014-2020
11.2.4 Europe Drug-Coated Balloons Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Drug-Coated Balloons Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Drug-Coated Balloons Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Drug-Coated Balloons Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Drug-Coated Balloons Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Drug-Coated Balloons Sales Assessment of Players 2014-2020
11.4.2 South America Drug-Coated Balloons Revenue Assessment of Players 2014-2020
11.4.3 South America Drug-Coated Balloons Price Assessment of Players 2014-2020
11.4.4 South America Drug-Coated Balloons Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Drug-Coated Balloons Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Drug-Coated Balloons Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Drug-Coated Balloons Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Drug-Coated Balloons Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Drug-Coated Balloons Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Drug-Coated Balloons Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Drug-Coated Balloons Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Drug-Coated Balloons Sales by Countries/Regions 2014-2020
12.2.2 North America Drug-Coated Balloons Revenue by Countries/Regions 2014-2020
12.2.3 North America Drug-Coated Balloons Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Drug-Coated Balloons Sales by Countries/Regions 2014-2020
12.3.2 Europe Drug-Coated Balloons Revenue by Countries/Regions 2014-2020
12.3.3 Europe Drug-Coated Balloons Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Drug-Coated Balloons Sales by Countries/Regions 2014-2020
12.4.2 South America Drug-Coated Balloons Revenue by Countries/Regions 2014-2020
12.4.3 South America Drug-Coated Balloons Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Drug-Coated Balloons Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Drug-Coated Balloons Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Drug-Coated Balloons Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Drug-Coated Balloons Sales & Revenue Forecast 2021-2026
14.1 World Drug-Coated Balloons Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Drug-Coated BalloonsSales and Market Share by Regions
14.1.2 World Drug-Coated BalloonsRevenue and Market Share by Regions
15 Asia Drug-Coated Balloons Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 By Material
15.1.2 Semi-Compliant Balloons
15.1.3 Non-Compliant Balloons
15.1.4 Type II
15.2 Consumption Forecast by Application, 2021-2026
16 North America Drug-Coated Balloons Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 By Material
16.1.2 Semi-Compliant Balloons
16.1.3 Non-Compliant Balloons
16.1.4 Type II
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Drug-Coated Balloons Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 By Material
17.1.2 Semi-Compliant Balloons
17.1.3 Non-Compliant Balloons
17.1.4 Type II
17.2 Consumption Forecast by Application, 2021-2026
18 South America Drug-Coated Balloons Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 By Material
18.1.2 Semi-Compliant Balloons
18.1.3 Non-Compliant Balloons
18.1.4 Type II
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Drug-Coated Balloons Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 By Material
19.1.2 Semi-Compliant Balloons
19.1.3 Non-Compliant Balloons
19.1.4 Type II
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Drug-Coated Balloons Price (USD/Unit) Trend 2021-2026
20.2 Global Drug-Coated Balloons Gross Profit Trend 2021-2026
21 Conclusion